With the recent battle between new Hepatitis C therapies, manufacturers are beginning to recognize the need for a shift in their analytic focus. How will the success of managed markets deals be evaluate from this point forward? Read more here. (Source: Brian Barbash, Finsights, 2/2/15)
You are here: / / How Is Success In Managed Markets Being Measured Now?